Substituted pyrazoles as corticotropin-releasing factor (CRF) antagonists
申请人:Pfizer Inc.
公开号:US05968944A1
公开(公告)日:1999-10-19
The compounds of the formula wherein A, R.sub.1, R.sub.3, X.sub.1, Y and Z are as defined herein, have corticotropin-releasing factor (CRF) antagonist activity. They are useful in the treatment of illnesses induced by CRF, such as stress and anxiety related disorders.